These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 32667830

  • 1. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M, Sandhu A, Soneji N, Amiras D, Rockall A, Messiou C, Wallitt K, Barwick TD.
    Br J Radiol; 2020 Nov 01; 93(1115):20200312. PubMed ID: 32667830
    [Abstract] [Full Text] [Related]

  • 2. How do we image patients with multiple myeloma and precursor states?
    Chakraborty R, Hillengass J, Lentzsch S.
    Br J Haematol; 2023 Nov 01; 203(4):536-545. PubMed ID: 37217164
    [Abstract] [Full Text] [Related]

  • 3. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
    Dutoit JC, Verstraete KL.
    Skeletal Radiol; 2017 Jun 01; 46(6):733-750. PubMed ID: 28289855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C.
    Eur Radiol; 2020 Jan 01; 30(1):320-327. PubMed ID: 31267214
    [Abstract] [Full Text] [Related]

  • 9. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucebci S, Tasu JP.
    Diagn Interv Imaging; 2013 Jun 01; 94(6):629-36. PubMed ID: 23683788
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
    Park GE, Jee WH, Lee SY, Sung JK, Jung JY, Grimm R, Son Y, Paek MY, Min CK, Ha KY.
    PLoS One; 2018 Jun 01; 13(12):e0208860. PubMed ID: 30557373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb 01; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma.
    Chen J, Li C, Tian Y, Xiao Q, Deng M, Hu H, Wen B, He Y.
    AJR Am J Roentgenol; 2019 Sep 01; 213(3):514-523. PubMed ID: 31166755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma.
    Wale A, Pawlyn C, Kaiser M, Messiou C.
    Haematologica; 2016 Apr 01; 101(4):e142-4. PubMed ID: 26819048
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.